Fluorocyclopentenylcytosine is under investigation in clinical trial NCT03189914 (RX-3117 in Combination With Abraxane® in Subjects With Metastatic Pancreatic Cancer).
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.